Schedule 13G ownership disclosure
Capricor Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 14070B309
Event date: 2026-01-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 3,399,900.00 · Class: 6.6%
- KEVIN TANG
Shares: 3,399,900.00 · Class: 6.6%
- TANG CAPITAL PARTNERS, LP
Shares: 2,337,350.00 · Class: 4.5%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 1,062,550.00 · Class: 2.1%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-26-000831
- Form type
- SCHEDULE 13G
- Filer
- CAPRICOR THERAPEUTICS, INC.
- CIK
- CIK 1133869
- Filed
- Jan 26, 2026
- Reporting period
- Jan 16, 2026
- Description
- Schedule 13G beneficial ownership